 |
|
 |
 |
Premium News Article
Merger Flu Lethal to Six Pfizer R&D Sites and 2,000 Employees
SAN DIEGO, CALIFORNIA--November 11, 2009--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Early Monday morning, the buzz at the International Society of Pharmaceutical Engineers (ISPE) conference in San Diego, California, was that Pfizer Incorporated (NYSE:PFE) (New York, New York) was planning to sell its massive St. Louis/Chesterfield, Missouri, research site to Monsanto Company (NYSE:MON) (St. Louis). By day's end, the truth had proven to be more dramatic than the rumors: To achieve a 35% reduction in global square footage, the company is going to close six research and development sites across the United States and lay off an estimated 2,000 people.
Read the Complete Article >>>
Details on this Article:
Industry Segment: Pharmaceutical & Biotech
Word Count: 448 Words
| Login or Register now for instant access! |
 |
Related Articles
Value of Industrial Project Starts in North America at $150 Billion for 200...

Industrial Info's World Expansion Helps Clients Uncover New Business Opport...

Project Management Excellence Promotes Project Success, by Pathfinder LLC, ...

Weird Science? Big Pharma's Top Three M&A Deals in 2009 Nears $160 Billion

Baltimore's Cel-Sci to Begin Production in $22 Million Aseptic Biopharma Pl...

|
|
 |
 |
|
 |
|
 |


This article is available for Premium Members only.
Subscribe Now! All Fields are Required...
Upgrade your Premium News Subscription to include all archived articles for only $160. Contact Member Services: 800-762-3361
All Members Receive the Following Free Resources:
North American Project & Gap Spending
North American Plant Analysis by Industry & Market Region
Market Maps & Stats - Capital & Maintenance Activity
Current & Historic Economic Indicators
30/60/90 Day Weather Forecast
|